The Ischemic Heart Disease Epitranscriptomics and Biomarkers (IHD-EPITRAN) study hypothesis states that the pathological features of IHD are mirrored in circulating cellular or extracellular epitranscriptomes. The study focuses on m6A modifications as well as A-to-I editing in blood RNA.